Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW CANAAN, CT--(Marketwire - January 21, 2010) - The Board of Directors of Marshall Edwards, Inc. today advised that analysis of tumor response data from the OVATURE trial will be performed in the...
-
WASHINGTON, DC--(Marketwire - January 14, 2009) - Marshall Edwards, Inc. (NASDAQ: MSHL) will present at the 27th Annual JPMorgan Healthcare Conference in San Francisco on Thursday January 15, 2008 at...
-
NEW CANAAN, CT--(Marketwire - December 1, 2008) - Marshall Edwards, Inc. (NASDAQ: MSHL) today announced that it has filed an application with the United States Food and Drug Administration for an...
-
NEW CANAAN, CT--(Marketwire - November 13, 2008) - The Independent Data Monitoring Committee (IDMC) constituted to oversee the conduct of the Phase III OVArian TUmor REsponse (OVATURE) Trial,...
-
NEW CANAAN, CT--(Marketwire - November 12, 2008) - The Independent Data Monitoring Committee (IDMC) constituted to oversee the conduct of the Phase III OVArian TUmor REsponse (OVATURE) Trial,...
-
STAMFORD, CT and SYDNEY, AUSTRALIA--(Marketwire - December 4, 2007) - A recently completed Phase Ib clinical trial of a new drug to treat inflammatory bowel disease (IBD) indicates that treatment may...
-
Research Indicates Synthetic Compound NV-52 May Be Useful in Treatment of Inflammatory Bowel Disease
NEW CANAAN, CT and SYDNEY, AUSTRALIA--(Marketwire - November 13, 2007) - An article published in a recent edition of the peer review journal Expert Opinion, Vol. 16, No. 8, reveals the compound...
-
SYDNEY, AUSTRALIA and BERLIN and NEW CANAAN, CT--(Marketwire - October 22, 2007) - A symposium on platinum resistant ovarian cancer will be held at the European Society for Gynecological Oncology in...